Managing Intrathecal Drug Delivery Devices in a Global Pandemic

Current perspectives on intrathecal drug delivery

Advances in intrathecal analgesia and intrathecal drug delivery systems have allowed for a range of medications to be used in the control of pain and spasticity. This technique allows for reduced medication doses that can decrease the side effects typically associated with oral or parenteral drug delivery. Recent expert panel consensus guidelines have provided care paths in the treatment of noc...

Microfabricated drug delivery devices.

We review newest developments in the design and fabrication of drug delivery devices based on micropatterned structures. Electronic devices have now reached a stage of dimensions comparable to those of biological macromolecules. This raises exciting possibilities for combining microelectronics and biotechnology to develop new technologies with unprecedented power and versatility. While molecula...

Fluid Mechanics of Intrathecal Drug Delivery

The aim of this principally experimental study is to understand from fluid mechanic principles why an insignificant anesthetic dose administered as a short bolus into the cerebrospinal fluid inside the subarachnoid space provides greater pain relief than a larger dose continuously injected over a longer period. The subarachnoid space is modeled as an annular gap of constant or slowly varying cr...

Recommendations for reducing infection in the practice of implanting spinal cord stimulation and intrathecal drug delivery devices: a physician's playbook.

Managing Process Assets in a Global IT Service Delivery Environment

At IBM, we recognize that our processes are our business. This is especially true in the area of IT Delivery where we have long been focused on the management and reuse of process assets. The current economic climate and advances in technology are rapidly driving IT Delivery to a truly global model. This transition greatly expands the scope of the process assets which need to be managed at a gl...